Axsome Therapeutics Inc.
AXSM | NASDAQ
$134.64
-$9.79 (-6.78%)
Nov 2, 2026, 3:19 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -191.64M | -188.3M | -183.17M | -229.53M | -246.9M | -278.27M | -287.22M | -310.96M | -308.55M | -296.38M | -239.24M | -201.83M | -184.45M | -158.72M | -187.13M | -159.87M | -149.93M | -140.78M | -130.4M | -125.59M | -113.63M | -99.68M |
Depreciation & Amortization | 8.11M | 8.76M | 8.12M | 7.91M | 7.56M | 7.85M | 7.96M | 7.63M | 7.31M | 6.69M | 6.83M | 7.11M | 7.33M | 7.23M | 5.56M | 3.85M | 2.19M | 1.2M | 1.16M | 909.49K | 615.27K | 343.37K |
Stock-Based Compensation | 96.42M | 93.88M | 93.75M | 93.01M | 91.57M | 88.34M | 85.22M | 82.15M | 75.33M | 69.87M | 62.62M | 54.47M | 48.83M | 43.07M | 37.73M | 32.85M | 29.37M | 24.67M | 20.8M | 20.52M | 17.66M | 16.35M |
Other Working Capital | 118.35M | 88.43M | 76.91M | 90.7M | 25.32M | 39.97M | 30.93M | 16.97M | 46.58M | 16.29M | 34.21M | 33.95M | 43.37M | 46.3M | 41.19M | 27.52M | 5.32M | 3.38M | 685.02K | 1.93M | 2.6M | -3.71M |
Other Non-Cash Items | 8.05M | 10.25M | 10.43M | 30.55M | 54.9M | 54.31M | 52.83M | 85.81M | 48.51M | 52.67M | 53.1M | 12.46M | 11.55M | 3.76M | 3.66M | -564.64K | -683.68K | -96.52K | -104.61K | 234.39K | 1.62M | 1.87M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -617K | -617K | n/a | n/a | 617K | 617K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 7.81M | 4.68M | -22.52M | -2.9M | -27.76M | 9.46M | 12.8M | 3.43M | 10.54M | -25.57M | -28.39M | -15.12M | 4.63M | 14.98M | 23.67M | 5.95M | -2.76M | 1.34M | 324.79K | 3.99M | 4.84M | -1.28M |
Operating Cash Flow | -71.26M | -70.73M | -93.41M | -100.95M | -120.63M | -118.32M | -128.41M | -132.57M | -167.49M | -192.73M | -145.08M | -142.28M | -111.49M | -89.68M | -116.51M | -117.79M | -121.81M | -113.66M | -108.23M | -99.94M | -88.9M | -82.4M |
Capital Expenditures | -129K | -263K | -480K | -439K | -231K | -270K | -30K | -7K | -528K | -609K | -582K | -755.86K | -450.91K | -559.37K | -702.11K | -213.7K | -406.32K | -183.74K | n/a | -327.84K | -84K | -66.56K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -53M | -53M | -53M | -53M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -571K | n/a | n/a | n/a | -240K | -240K | -240K | -240K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -307.55B | -307.55B | -307.55B | -307.55B | n/a | n/a | n/a |
Investing Cash Flow | -700K | -263K | -480K | -439K | -471K | -510K | -270K | -247K | -528K | -609K | -582K | -755.86K | -450.91K | -53.56M | -53.7M | -307.6B | -307.6B | -307.55B | -307.55B | -327.84K | -84K | -66.56K |
Debt Repayment | -3.09M | -8.02M | -7.75M | -7.54M | -7.19M | -1.23M | -990K | 195K | -350K | 29.84M | 83.78M | 82.93M | 83.78M | 98.78M | 45M | 45M | 45M | n/a | n/a | 1.1M | 29.44M | 29.44M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -25.78M | -22.99M | -408K | 1.74M | 22.7M | 22.58M | 9.03M | 8.87M | -8.27M | -13.97M | -13.05M | -12.81M | -14.39M | -7.55M | -5.04M | -3.68M | -2.58M | 385.25K | 2.39M | 1.73M | 812.65K | 128.17K |
Financial Cash Flow | 88.79M | 75.19M | 101.47M | 99.32M | 108.46M | 88.3M | 57.84M | 43.59M | 46.56M | 278.26M | 331.01M | 332.08M | 475.66M | 305.05M | 284.58M | 284.21M | 107.7M | 34.2M | 11.13M | 12.53M | 39.52M | 49.81M |
Net Cash Flow | 16.83M | 4.2M | 7.58M | -2.07M | -12.64M | -30.53M | -70.84M | -89.22M | -121.46M | 84.93M | 185.35M | 189.04M | 363.72M | 161.81M | 114.37M | 112.9M | -67.82M | -79.95M | -97.4M | -87.74M | -49.46M | -32.65M |
Free Cash Flow | -71.39M | -70.99M | -93.89M | -101.39M | -120.86M | -118.59M | -128.44M | -132.58M | -168.02M | -193.34M | -145.66M | -143.04M | -111.94M | -90.24M | -117.21M | -118M | -122.21M | -113.85M | -108.23M | -100.27M | -88.98M | -82.47M |
Adj. Free Cash Flow | -167.81M | -164.88M | -187.64M | -194.4M | -212.43M | -206.92M | -213.66M | -214.72M | -243.34M | -263.2M | -208.28M | -197.51M | -160.77M | -133.31M | -154.94M | -150.85M | -151.59M | -138.52M | -129.03M | -120.78M | -106.64M | -98.82M |
Maintenance CapEx | -242K | -121K | n/a | n/a | 300K | 300K | 202K | 202K | -98K | -98K | n/a | n/a | n/a | n/a | -213.74K | -521.15K | -779.82K | -798.7K | -614.96K | -327.84K | -74.68K | -57.23K |
Growth CapEx | 113K | -142K | -480K | -439K | -531K | -570K | -232K | -209K | -430K | -511K | -582K | -755.86K | -450.91K | -559.37K | -488.37K | 307.44K | 373.5K | 614.96K | 614.96K | n/a | -9.32K | -9.32K |
Owner Earnings | -71.5M | -70.85M | -93.41M | -100.95M | -120.33M | -118.02M | -128.21M | -132.37M | -167.59M | -192.82M | -145.08M | -142.28M | -111.49M | -89.68M | -116.72M | -118.31M | -122.59M | -114.46M | -108.84M | -100.27M | -88.97M | -82.46M |
Add to Watchlist
Select watchlists to add or remove AXSM